Allogene Therapeutics (ALLO) EPS (Basic) (2018 - 2026)
Allogene Therapeutics (ALLO) reported EPS (Basic) of -$0.6 for Q1 2026, down 76.45% on a YoY basis from -$2.57 in Q1 2025, and down 241.36% sequentially from -$0.18 in Q4 2025.
Allogene Therapeutics (ALLO) EPS (Basic) (2018 - 2026) Analysis & Trends
Allogene Therapeutics (ALLO) has 9 years of EPS (Basic) data on file, last reported at -$0.6 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 76.45% year-over-year to -$0.6; the trailing twelve-month figure through Mar 2026 stood at -$1.36 (up 27.35% YoY), and the FY2025 full-year result was -$0.87, up 34.57% from the prior year.
- EPS (Basic) fell to -$0.6 in Q1 2026, from -$0.18 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.18 in Q4 2025 to a low of -$1.57 in Q3 2022.
- A 5-year average of -$0.59 and a median of -$0.55 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) slumped 1362644.41% in 2022 and soared 65.51% in 2025, its largest moves.
- Tracing ALLO's EPS (Basic) over 5 years: stood at -$0.7 in 2022, then soared by 33.91% to -$0.46 in 2023, then soared by 36.36% to -$0.3 in 2024, then jumped by 40.07% to -$0.18 in 2025, then sank by 241.36% to -$0.6 in 2026.
- Business Quant data shows ALLO's EPS (Basic) at -$0.6 in Q1 2026, -$0.18 in Q4 2025, and -$0.29 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Allogene Therapeutics | 421.71 Mn | 421.71 Mn | - | -0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -0.18 |
| Sep 30, 2025 | -0.29 |
| Jun 30, 2025 | -0.35 |
| Mar 31, 2025 | -0.34 |
| Dec 31, 2024 | -0.30 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -1.01 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.77 |
| Mar 31, 2023 | -0.69 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -1.57 |
| Jun 30, 2022 | -0.76 |
| Mar 31, 2022 | -0.58 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | -1.17 |
| Jun 30, 2021 | -1.09 |